Results 161 to 170 of about 364,779 (302)

Editorial: Chronic inflammation, oxidative stress and lipoprotein metabolism in cardio-pulmonary continuum. [PDF]

Front Cardiovasc Med, 2022
Sorokin AV, Arnardottir H, Kotani K, Silbernagel G.   +3 more
europepmc   +1 more source

Generating golden Syrian hamsters with conditional alleles via zygote microinjection of CRISPR/Cas9

Animal Models and Experimental Medicine, EarlyView.
We established the first conditional knockout (cKO) model in the golden Syrian hamster by CRISPR/Cas9‐mediated genome editing. Cas9 protein, two sgRNAs, and a donor plasmid carrying loxP‐flanked exon 2 of the ApoF gene were microinjected into one‐cell embryos. The floxed allele was efficiently generated (up to 27%) and transmitted through the germline.
Wei Chen, Xu Zhang, Rui Fan, Xia Li, Feifei Guan, Gefan Wan, Weining Kong, Xiaolong Qi, Shuo Pan, Sijing Shi, Yuanlong Su, Shan Gao, Wei Huang, Xunde Xian, Jiangning Liu, Yuhui Wang, Yuanwu Ma   +16 more
wiley   +1 more source

Tomatoes, lysophosphatidic acid, and the small intestine: new pieces in the puzzle of apolipoprotein mimetic peptides?1

Journal of Lipid Research, 2013
A.T. Remaley
doaj   +1 more source

Correction: Bioinformatic analysis identifies LPL as a critical gene in diabetic kidney disease via lipoprotein metabolism. [PDF]

Front Endocrinol (Lausanne)
Dong Q, Xu H, Xu P, Liu J, Shen Z.
europepmc   +1 more source

Impact of Sepsis on High-Density Lipoprotein Metabolism. [PDF]

Front Cell Dev Biol, 2021
Reisinger AC, Schuller M, Sourij H, Stadler JT, Hackl G, Eller P, Marsche G.   +6 more
europepmc   +1 more source

Quantitative proteomics identifies clusterin as a novel biomarker for atherosclerosis

Animal Models and Experimental Medicine, EarlyView.
This schematic illustrates the proposed mechanism. In advanced atherosclerotic lesions, upregulated CLU on the cell surface activates low‐density lipoprotein (LDL) receptor‐related protein 1 (LRP1). This interaction triggers the phosphorylation and activation of AKT.
Dengfeng Ding, Yingjie Zhang, Li Zhang, Xinou Zheng, Miaomiao Niu, Yunxiao Jia, Xuezhuang Li, Hua Chen, Chao Guo, Tao Jiang, Yuqiong Zhao   +10 more
wiley   +1 more source

Hepatic Lipoprotein Metabolism: Current and Future In Vitro Cell-Based Systems. [PDF]

Biomolecules
Kiss I, Neuwert N, Oberle R, Hengstschläger M, Osmanagic-Myers S, Stangl H.   +5 more
europepmc   +1 more source

Apolipoprotein F is reduced in humans with steatosis and controls plasma triglyceride-rich lipoprotein metabolism. [PDF]

Hepatology, 2023
Deprince A, Hennuyer N, Kooijman S, Pronk ACM, Baugé E, Lienard V, Verrijken A, Dirinck E, Vonghia L, Woitrain E, Kloosterhuis NJ, Marez E, Jacquemain P, Wolters JC, Lalloyer F, Eberlé D, Quemener S, Vallez E, Tailleux A, Kouach M, Goossens JF, Raverdy V, Derudas B, Kuivenhoven JA, Croyal M, van de Sluis B, Francque S, Pattou F, Rensen PCN, Staels B, Haas JT.   +30 more
europepmc   +1 more source

Amyotrophic Lateral Sclerosis and Frontotemporal Dementia Have Distinct Prediagnostic Blood Biochemical Profiles

Annals of Neurology, EarlyView.
Objective Identifying modifiable factors influencing amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) risk is important for prevention. Blood biomarkers, particularly cholesterol, have been associated with neurodegenerative risk, but findings in ALS are inconsistent, and data on FTD are limited.
Christos V. Chalitsios, Jiali Gao, Carol A.C. Coupland, Julia Hippisley Cox, Martin R. Turner, Alexander G. Thompson   +5 more
wiley   +1 more source

Bioinformatic analysis identifies LPL as a critical gene in diabetic kidney disease via lipoprotein metabolism. [PDF]

Front Endocrinol (Lausanne)
Dong Q, Xu H, Xu P, Liu J, Shen Z.
europepmc   +1 more source